RE: PAUL SCOTT comments - Stockopedia2 Nov 2021 12:40
OldGeorge I sold a few weeks ago @ 182p fearing costly supply chain issues, having seem the S/P dive. But re-bought first thing at 179p. So lucky to not lose out. Well done you, for hanging on. It pays to stay long here....
There’s not much comment on the supply chain situation, which is why sentiment moderated here in the first place, but perhaps that should be taken as a positive given the expectation of continued growth.
The folks over at Equity Development have a new note out and a fair value target of 275p. They expect adjusted earnings per share to continue increasing, from 10.6p this year to 14.1p next year and 15.3 the year after that. It’s a comprehensive note and well worth the read, far more thorough than you might see elsewhere for other companies.
There have been two recent acquisitions, with Salter looking particularly sensible. It’s a sizable and significant purchase that means UPGS shares continue to look reasonably valued even after the recent increase. It’s worth remembering that despite clocking up double digit long term growth CAGRs, the group is forecast to pay a 3.7% dividend in FY22 at the current share price.
M&A might well become a more regular feature in future as UPGS continues to drive growth. Online is performing well and the group’s move into supermarkets could see its branded products take share. International will also likely become more significant in the years ahead.
I would view any freight-related disruption as a temporary headwind that UPGS, as a quality operator, is able to navigate. Reports suggest these issues could last into 2023, so the problem should not be taken lightly, but I suspect the negative reaction to supply chain fears might end up proving to be a reasonable entry point.
Feedback (FDBK) £10.5m placing and OO at 0.7p, a 12% discount, to support accelerated growth. [SP=0.8 Cap=9m]
Cambridge Cognition (COG) CFO scarpers. He is not thanked. [SP=136.1 Cap=42m]
Sensyne Health (SENS) hoists the For Sale sign after COE looks at MBO. Co "believes that the current market value of the Company does not reflect the fair value of the electronic patient record ("EPR") health data to which the Company has access". [SP=94 Cap=155m]
Avacta (AVCT) stops sale of AffiDX rapd covid test due to UK Health Security Agency's Medical Devices requiring a review of test data.. Can restart if it passes. "Avacta submitted, ahead of the 1 September 2021 deadline, all the information required for its AffiDX test to be validated under these regulations by the UK Health Security Agency." [SP=118 Cap=299m].
Warpaint London (W7L) guides FY(Dec) rev and adj EBITDA ahead of market expectations with rev flat on 2019 [SP=150.41 Cap=115m]
James Fisher (FSJ) sells James Fisher Testing Services for £5.7m. No NAV or profit fig given. [SP=417.54 Cap=210m]
Watkin Jones (WJG) guides FY(Sep) rev slightly below expectations (whose?) but op profit in line. [SP=242 Cap=620m]
Novacyt (NCYT) can only sell one covid test until the UK Health Security Agency completes its review of the additional nine products submitted. If no further products are added to the CTDA register the this FY rev hit c. £3m. £20m annualised? [SP=253.3 Cap=213m]
Electra Private Equity (ELTA) the demerged Hostmore (MORE) lists today. remaining biz Hotter trading "strong and extremely pleasing in light of the market wide supply chain issues". 12 months to OCt rev £50.4m with margins in line. [SP=550 Cap=214m].
Gaming Realms (GMR) Michigan gaming licences becomes full (from provisional). Q3 content licensing revenue increased 35% year on year, new licensing and games pipeline has also grown. In line? [SP=38.5 Cap=111m]
Up Global Sourcing (UPGS) FY. Current trading in line. [SP=173 Cap=155m]
The thousands of delegates, diplomats, leaders and luminaries arriving this morning are, let’s be honest, not getting the U.K. at its best. Hundreds of COP attendees were stranded at Euston Station yesterday as fallen trees caused the closure of the West Coat Main Line and absolute chaos for anyone trying to get from London to Glasgow. Playbook’s thoughts were with Lobby journalists who had a miserable time getting across the country. Some who were turned away at Euston resorted to last-minute domestic short-haul flights. Others hired cars from Watford for the seven-plus hour drive. Sky’s Samantha Washington was quoted £870 for a taxi from Edinburgh to Glasgow. Special mention for the i’s Paul Waugh, who managed to board a train to Glasgow which made it to Milton Keynes before turning round and returning to London. Makes you proud to be British.
Tax is up, rent is up, electricity, water, and gas bills up, food costs up, import and export costs for business up, Covid cases up, labour shortages up, NHS waiting lists up.
Shoe Zone (SHOE) hike FY(Oct) pretax guidance to £9-10m. Cites good trading, exchange rates and not having to put £1.5m one off additional pension contributions through P/L. [SP=90.5 Cap=45m]
TP Group (TPG) changes following investment by Science Group. CEO resigns, expects to leave in March. Co will focus on the UK-based Defence and Aerospace operations. Review of strategy of other ops. Trading broadly in line with market expectations [SP=5.19 Cap=39m]
Active Energy (AEG) gets Canada patent for for CoalSwitch. [SP=0.35 Cap=14m]
Allied Minds (ALM) sells holding in Spark Insights for only $700k in paper. "A previously reported, due to challenges posed by COVID-19, it has faced delays in fundraising for the continuing operation of the business." [SP=23 Cap=55m]
Sportech (SPO) exclusive talks to sell its terrestrial lottery supply contract extended to Dec 1. [SP=37.35 Cap=72m]
BATM Advanced Communications (BVC) €900k contract for agri-waste treatment solution in Botswana. [SP=83.9 Cap=370m]
KRM22 (KRM) £4.7m conditional private placing at 53p, a 58% premium. Warns H2 rev and adj EBITDA flat on H1, below expectations. Cites delay of significant tier one bank agreement to FY23. FY 2022 forecasts remain positive. [SP=32.25 Cap=9m]
Omega Diagnostics (ODX) partnership with DAM Health , a leader in fit-to-fly testing. Co to supply VISITECT professional use covid LFT.. May broaden the partnership to include VISITECT antigen self-test LFT [SP=48.85 Cap=89m]
LoopUp (LOOP) major strategic sales and distribution 'alliance' to resell Cloud Telephony with a leading international telecommunications provider. [SP=22.75 Cap=22m]
Nanosynth (NNN) sells Cloudveil to founder for nowt as co focusses on core capabilities. COO has resigned from the Board to focus on product management activities within P2F, co's main subsidiary. [SP=0.71 Cap=15m]
IXICO (IXI) £1m+ 7 year contract for clinical trial. Already included in rev expectations. [SP=71 Cap=34m]
The Brexit trade deal allows French fishers to continue to operate in the Channel Islands’ waters, as long as they can prove they had previously been fishing there. British authorities acknowledge that many small boats struggle to find sufficient evidence because they did not carry GPS systems onboard. French fishermen, however, argue they have meticulously kept paper logbooks that prove they were operating legally in British waters before Brexit.
“They are acting in bad faith,” said Stéphane Pinto, the deputy head of the regional fishing committee in Boulogne-sur-Mer. “The U.K. is hiding behind this [GPS] excuse, we have plenty of proof that we were fishing in British waters before Brexit.”